Apheresis Market Worth $3.9 billion | MarketsandMarkets™ [Yahoo! Finance]
Haemonetics Corporation (HAE)
Last haemonetics corporation earnings: 2/4 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=72118&p=irol-irhome
Company Research
Source: Yahoo! Finance
billion by 2029, growing at a CAGR of 8.8% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the apheresis market is driven by rise in demand for source plasma from biopharmaceutical companies, upsurging demand for blood components and favourable reimbursement for apheresis. The increasing investments from government bodies and leading players poses a lucrative opportunity in the apheresis market. But strict donor recruitment criteria are restraining the apheresis market during the forecast period. Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=950 Browse in-depth TOC on "Apheresis Market" 376 - Tables 65 - Figures 343 - Pages Apheresis Market Scope: Report Coverage Details Market Revenue in 2024 $2.6 billion Estimated Value by 2029 $3.9 billion Growth Rate Poised to grow at a CAGR of 8.8% Market Size Available for 2021–2029 Forecast Period 2024–2029 Forecast Units Value (U
Show less
Read more
Impact Snapshot
Event Time:
HAE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HAE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HAE alerts
High impacting Haemonetics Corporation news events
Weekly update
A roundup of the hottest topics
HAE
News
- Global $3.9 Bn Apheresis Market Forecast to 2029: Surge in Use for Leukaemia and Paediatric Patients Boosts Growth Prospects [Yahoo! Finance]Yahoo! Finance
- Haemonetics Co. (NYSE: HAE) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $105.00 price target on the stock.MarketBeat
- Why You Should Add Haemonetics (HAE) to Your Portfolio Now [Yahoo! Finance]Yahoo! Finance
- Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024 [Yahoo! Finance]Yahoo! Finance
- Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024PR Newswire
HAE
Earnings
- 2/8/24 - Beat
HAE
Sec Filings
- 4/17/24 - Form 4
- 4/1/24 - Form 8-K
- 3/13/24 - Form 4
- HAE's page on the SEC website